← Back to patent-cliff list
CAS 607722-95-2
(Z)-5-(4-(2-((6-(4-methoxyphenoxy)pyrimidin-4-yl)(methyl)amino)ethoxy)benzylidene)thiazolidine-2,4-dione
Codes: LOBE-009
Application context (from source-drug indications)
Type 2 diabetesLobeglitazone SulfateGastroparesisLobeglitazone SulfateRenal impairmentLobeglitazone SulfateAbnormal liver functionLobeglitazone Sulfate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Lobeglitazone Sulfate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4,6-dichloropyrimidine→4-methoxyphenol→4-chloro-6-(4-methoxyphenoxy)pyrimidine→2-(methylamino)ethan-1-ol→2-((6-(4-methoxyphenoxy)pyrimidin-4-yl)(methyl)amino)ethanol→4-fluorobenzaldehyde→4-(2-((6-(4-methoxyphenoxy)pyrimidin-4-yl)(methyl)amino)ethoxy)benzaldehyde→thiazolidine-2,4-dione→(Z)-5-(4-(2-((6-(4-methoxyphenoxy)pyrimidin-4-yl)(methyl)amino)ethoxy)benzylidene)thiazolidine-2,4-dione
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.